Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Published 2019 Apr 12
Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases
Microbiome 6 (1), 226
Focus on interpretability, fairness, and prospective real-world validation to ensure that AI-based models provide incremental value over existing standard-of-care risk stratification approaches
Switching from tirzepatide or semaglutide to retatrutide If you are switching from tirzepatide to retatrutide , you have an advantage
US$ 22.74
US$ 27.09
US$ 23.68
US$ 22.61
US$ 29.05
US$ 24.56
US$ 28.58
